This clinical-stage biotech specializing in blood disorders reported a notable insider sale amid strong recent stock performance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback